News & Articles
Selected Filters:
Improving acquisition and analysis of 3D cell model assays with water immersion objectives
Sebastian Peck discusses an automated high-content imaging solution designed to deliver more precise results from complex biological assays
Help us celebrate 30 years of BMG LABTECH
SelectScience goes behind the scenes to meet some of the key people driving the microplate reader innovator
A total workflow for multi-class, multi-residue analysis of pesticides in fatty food matrices: Your questions answered
Watch this on-demand webinar to learn strategies for sample preparation, instrument method development and optimization, plus workflow applicability to their practical applications
Thermo Fisher announces collaborations to meet unmet clinical needs in biomarker discovery and characterization
Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
Bio-Rad introduces StarBright Violet 515 Dye for flow cytometry
New dye offers researchers improved brightness to resolve rare and low antigen density populations more easily
New for NanoDrop: 21 CFR part 11 & distinguishing DNA from RNA
Join us on Thursday, September 24, to learn more about new updates of the NanoDrop One platform
PCR Biosystems launches RiboShield RNase Inhibitor to ensure reliable RNA protection
RiboShield RNase Inhibitor complements PCR Biosystems’s range of products to support COVID-19 research and testing
Increasing CRISPR editing efficiency with novel guide RNA methods
Join us to gain an overview of recent technological advances in CRISPR/Cas gene editing
Oxford University researchers target previously unknown ‘genetic vulnerability’ in breast cancer cells
The study has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumors
Ceres Nanosciences receives $6.5M NIH Award
The award money will help to expand Nanotrap Particle manufacturing capacity for COVID-19 testing
Evaluate convalescent plasma, antibody therapies, and vaccines for COVID-19 with Leinco Technologies’ novel ELISA kit
Leinco Technologies has launched the COVID-19 ImmunoRank Neutralization ELISA Test Kit
First FDA Approved CDx for RET fusion-positive metastatic non-small cell lung cancer (NSCLC)
This makes the Oncomine Dx Target Test the first NGS-based companion diagnostic for RET fusion-positive NSCLC and expands the test’s utility
Important considerations for choosing a SARS-CoV-2 assay: Your questions answered
Watch this on-demand webinar to discover the critical factors when choosing an assay for coronavirus testing
Automation-enabled assay development for high throughput screening
Join us on Monday, September 21, to learn about assay development for high-throughput screening
FDA approves first NGS-based companion diagnostic for RET fusion-positive non-small cell lung cancer
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
Roche granted FDA clearance for BK virus test to support better care for transplant patients
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus























